To commercialize psychedelic drugs, they first have to be legalized. In the United States, an important ally in this battle has surfaced: the DoD.

Another incremental step forward in one of MindMed’s leading psychedelics R&D initiatives.

A legal memo on cannabis legalization from an Israeli inter-ministerial committee is set to be drafted into a bill that could come to the Knesset floor for a vote before the year’s end.